Authors:
Delarue, F
Hertig, A
Alberti, C
Vigneau, C
Ammor, M
Berrou, J
Akposso, K
Peraldi, MN
Rondeau, E
Sraer, JD
Citation: F. Delarue et al., Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys, TRANSPLANT, 72(7), 2001, pp. 1256-1261
Citation: F. Suzan et al., Fatal reactivation of cytomegalovirus infection after use of rituximab fora post-transplantation lymphoproliferative disorder., N ENG J MED, 345(13), 2001, pp. 1000-1000
Authors:
Khoury, N
Kriaa, F
Hiesse, C
Von Ey, F
Durbach, A
Ammor, M
Hafi, A
Djeffal, R
Boubenider, S
Droupy, S
Hammoudi, Y
Eschwege, P
Benoit, G
Charpentier, B
Citation: N. Khoury et al., Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression, TRANSPLAN P, 32(8), 2000, pp. 2763-2764
Authors:
Djeffal, R
Hiesse, C
Kriaa, F
Hafi, A
Boubenider, S
Ammor, M
Durrbach, A
Von Ey, F
Droupy, S
Hammoudi, Y
Eschwege, P
Benoit, G
Charpentier, B
Citation: R. Djeffal et al., Treatment with mycophenolate mofetil in long-term renal transplant recipients: Single-center experience in 28 patients, TRANSPLAN P, 32(8), 2000, pp. 2765-2766
Authors:
Charpentier, B
Hiesse, C
Marchand, S
Boubenider, S
Ammor, M
Kechrid, C
Benoit, G
Durrbach, A
Citation: B. Charpentier et al., Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies, TRANSPLAN P, 32(2), 2000, pp. 367-367